Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -23.29 | N/A |
PEG Ratio (TTM) | 0.07 | N/A |
P/S Ratio (TTM) | 1.14 | N/A |
P/B Ratio (TTM) | 1.50 | N/A |
P/FCF Ratio (TTM) | -8.09 | N/A |
Price to 5YR AVG Earnings Ratio | -144.94 | N/A |
Price to 5YR AVG FCF Ratio | 61.95 | N/A |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.55% | N/A |
ROE (TTM) | -6.94% | N/A |
Net Profit Margin (TTM) | -4.87% | N/A |
ROIC 5YR AVG | 6.18% | N/A |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -104.97% | -254.03% | -9.44% |
Revenue | -9.41% | -4.21% | 21.76% |
Net Income | -116.68% | -252.04% | -5.29% |
Cash Flow | -21.70% | 0.96% | 5.10% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.58 | N/A |
Quick Ratio (TTM) | 0.17 | N/A |
D/E Ratio (TTM) | 0.21 | N/A |
Interest Coverage (TTM) | -0.92 | N/A |
Piotroski F-Score | 7 | N/A |
Altman Z-Score | 1.92 | N/A |
LTL to 5YR AVG FCF | 11.78 | N/A |
Shares Outstanding Growth 5YR AVG | 1.97% | N/A |